In this study, we conducted a comprehensive mutational analysis of HCC samples from a cohort of 39 patients with mutations, focusing on key driver genes such as TP53, CTNNB1, AXIN1, and KRAS. This evidence concerns the gene TP53 and hepatocellular carcinoma.